FLUCONAZOLE Ирландия - английский - HPRA (Health Products Regulatory Authority)

fluconazole

claris lifesciences (uk) limited - fluconazole - solution for infusion - 2 mg/ml - fluconazole

RANITIDINE CLARIS Ирландия - английский - HPRA (Health Products Regulatory Authority)

ranitidine claris

claris lifesciences (uk) limited - ranitidine hydrochloride - solution for inj/inf - 25 base mg/ml

RANITIDINE CLARIS 25 Base mg/ml Solution for Inj/Inf Ирландия - английский - HPRA (Health Products Regulatory Authority)

ranitidine claris 25 base mg/ml solution for inj/inf

claris lifesciences (uk) limited - ranitidine hydrochloride - solution for inj/inf - 25 base mg/ml

BUPIVACAINE 2.5 Mg/Ml Solution for Injection Ирландия - английский - HPRA (Health Products Regulatory Authority)

bupivacaine 2.5 mg/ml solution for injection

claris lifesciences (uk) limited - bupivacaine hydrochloride - solution for injection - 2.5 mg/ml - amides

BUPIVACAINE 5.0 Mg/Ml Solution for Injection Ирландия - английский - HPRA (Health Products Regulatory Authority)

bupivacaine 5.0 mg/ml solution for injection

claris lifesciences (uk) limited - bupivacaine hydrochloride - solution for injection - 5.0 mg/ml - amides

CLARISCAN gadoteric acid 5.586g/20mL solution for injection vial Австралия - английский - Department of Health (Therapeutic Goods Administration)

clariscan gadoteric acid 5.586g/20ml solution for injection vial

ge healthcare australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - solution - excipient ingredients: meglumine; water for injections; tetraxetan - clariscan is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).

CLARISCAN gadoteric acid 2.793g/10mL solution for injection vial Австралия - английский - Department of Health (Therapeutic Goods Administration)

clariscan gadoteric acid 2.793g/10ml solution for injection vial

ge healthcare australia pty ltd - gadoteric acid, quantity: 279.32 mg/ml - solution - excipient ingredients: meglumine; water for injections; tetraxetan - clariscan is indicated, in adults and children, for use with magnetic resonance imaging to provide contrast enhancement for intracranial and spinal lesions with abnormal blood brain barrier or abnormal vascularity, and for whole body imaging (see clinical studies).